CIDE-B Antibodies

Santa Cruz Biotechnology provides a broad selection of CIDE-B monoclonal antibodies for advanced research in cell biology. CIDE-B monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CIDE-B, or Cell Death Inducing DFFA-Like Effector B, plays a crucial role in the regulation of apoptosis and cellular stress responses. CIDE-B is involved in the modulation of lipid metabolism and has been implicated in various pathological conditions, including obesity and metabolic disorders. Understanding CIDE-B function is essential for elucidating potential therapeutic targets in diseases related to cell death and survival. Researchers worldwide rely on CIDE-B monoclonal antibodies to investigate cellular pathways and molecular mechanisms. CIDE-B monoclonal antibodies enable precise detection and characterization of protein expression patterns across diverse experimental applications. Santa Cruz Biotechnology monoclonal antibodies for CIDE-B support researchers in advancing scientific knowledge and developing innovative therapeutic strategies.